Menu
  • Video
  • Audio
  • Images
  • Collections
  • About
Sign in
ASRS A project from the American Soceity of Retina Specialists
Share feedback      Sign in
ASRS Multimedia Library
ASRS A project from the American Society of Retina Specialists
Search by condition, keyword, or author name
  • Video
  • Audio
  • Images
  • Collections
  • About
  1. Collections
  2. Updates from the Field

Sign in to view content

Sign in

Randomized Trial of Initiating Therapy With Aflibercept, Laser, or Observation for Eyes With Good Vision and Center-Involved Diabetic Macular Edema

  • Carl W. Baker, MD, FASRS
  • Video
  • Published 2019

Related

  • Silicone Droplets are Released by Syringes and Found in the Vitreous

    Gustavo Barreto de Melo, MD, PhD, FASRS

    Annual Meeting Talks

    2019

  • FIDO Study: 10-Year Outcomes of Eyes Receiving Continuous, Fixed-Interval Dosing of Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration

    Ivan J. Suner, MD, MBA

    Annual Meeting Talks

    2019

  • Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER

    Arshad M. Khanani, MD, MA, FASRS

    Annual Meeting Talks

    2018

Category: Diabetic Retinopathy

  • Anti-VEGF Agents
  • Diabetic Macular Edema
  • clinical trials
  • drcr.net
  • protocol v
  • good vision

See more

  • Updates from the Field
  • Carl W. Baker, MD, FASRS
  • ASRS Multimedia Library
  • Video
  • Audio
  • Images
  • Collections
American Society of Retina Specialists5315 North Clark Street, Suite 311, Chicago, Illinois 60640(312) 578-8760 phoneinfo@asrs.org
© 2026 The American Society of Retina Specialists. All rights reserved. Privacy statement. Terms of use.